Wells Fargo & Company Celcuity Inc. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CELC
# of Institutions
93Shares Held
30.1MCall Options Held
4.8KPut Options Held
126K-
Bvf Inc San Francisco, CA3.47MShares$54.4 Million1.74% of portfolio
-
Morgan Stanley New York, NY2.84MShares$44.5 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$37.1 Million1.12% of portfolio
-
Baker Bros. Advisors LP New York, NY1.87MShares$29.4 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.57MShares$24.6 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $234M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...